Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   The D2 and D3 sublineages of human papillomavirus 16-positive cervical cancer in Guatemala differ in integration rate and age of diagnosis
  2. Lou,Hong; Boland,Joseph; Torres-Gonzalez, Edmundo; Albanez, Anaseidy; Zhou,Weiyin; Steinberg,Mia; Diaw, Lena; Mitchell, Jason; Roberson, David; Cullen,Michael; Garland,Lisa; Bass,Sara; Burk, Robert D; Yeager,Meredith; Wentzensen, Nicolas; Schiffman, Mark; Alvirez Freites, Enrique; Gharzouzi, Eduardo; Mirabello, Lisa; Dean, Michael
  3. Cancer research. 2020, SEP 15; 80(18): 3803-3809.
  1. 2.   Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
  2. Burks, Julian; Nadella, Sandeep; Mahmud, Abdullah; Mankongpaisarnrung, Charoen; Wang, Juan; Hahm, Jong-In; Tucker, Robin D; Shivapurkar, Narayan; Stern, Steve; Smith, Jill P
  3. Cellular and Molecular Gastroenterology and Hepatology. 2018, Mar 07; 6(1): 17-32.
  1. 3.   Altered distribution of mucosal NK cells during HIV infection
  2. Sips, M.; Sciaranghella, G.; Diefenbach, T.; Dugast, A. S.; Berger, C. T.; Liu, Q.; Kwon, D.; Ghebremichael, M.; Estes, J. D.; Carrington, M.; Martin, J. N.; Deeks, S. G.; Hunt, P. W.; Alter, G.
  3. Mucosal Immunology. 2012, Jan; 5(1): 30-40.
  1. 4.   Alterations of T-cell surface markers in older women with persistent human papillomavirus infection
  2. Rodriguez, A. C.; Garcia-Pineres, A. J.; Hildesheim, A.; Herrero, R.; Trivett, M.; Williams, M.; Atmella, I.; Ramirez, M.; Villegas, M.; Schiffman, M.; Burk, R.; Freer, E.; Bonilla, J.; Bratti, C.; Pinto, L. A.
  3. International Journal of Cancer. 2011, Feb; 128(3): 597-607.
  1. 5.   Human papillomavirus false positive cytological diagnosis in low grade squamous intraepithelial lesion
  2. Nunez-Troconis, J.; Delgado, M.; Gonzalez, J.; Velasquez, J.; Mindiola, R.; Whitby, D.; Conde, B.; Munroe, D. J.
  3. Investigacion Clinica. 2009 50(4): 447-454.
  1. 6.   Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): Novel marker for cervical carcinogenesis
  2. Miyatake, T.; Ueda, Y.; Nakashima, R.; Yoshino, K.; Kimura, T.; Murata, T.; Nomura, T.; Fujita, M.; Buzard, G. S.; Enomoto, T.
  3. International Journal of Cancer. 2007, May; 120(10): 2068-2077.
  1. 7.   Identification of a unique epigenetic sub-microenvironment in prostate cancer
  2. Rodriguez-Canales, J.; Hanson, J. C.; Tangrea, M. A.; Erickson, H. S.; Albert, P. S.; Wallis, B. S.; Richardson, A. M.; Pinto, P. A.; Linehan, W. M.; Gillespie, J. W.; Merin, M. J.; Libutti, S. K.; Woodson, K. G.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Journal of Pathology. 2007, Mar; 211(4): 410-419.
  1. 8.   TGFBR3 loss and consequences in prostate cancer
  2. Sharifi, N.; Hurt, E. M.; Kawasaki, B. T.; Farrar, W. L.
  3. Prostate. 2007, Feb; 67(3): 301-311.
  1. 9.   Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Herrero, R.; Trivett, M.; Williams, M.; Atmetlla, I.; Ramirez, M.; Villegas, M.; Schiffman, M.; Rodriguez, A. C.; Burk, R. D.; Hildesheim, M.; Freer, E.; Bonilla, J.; Bratti, C.; Berzofsky, J. A.; Pinto, L. A.
  3. Cancer Research. 2006, Nov; 66(22): 11070-11076.
  1. 10.   Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations
  2. Hruban, R. H.; Adsay, N. V.; Albores-Saavedra, J.; Anver, M. R.; Biankin, A. V.; Boivin, G. P.; Furth, E. E.; Furukawa, T.; Klein, A.; Klimstra, D. S.; Kloppel, G.; Lauwers, G. Y.; Longnecker, D. S.; Luttges, J.; Maitra, A.; Offerhaus, G. J. A.; Perez-Gallego, L.; Redston, M.; Tuveson, D. A.
  3. Cancer Research. 2006, Jan 1; 66(1): 95-106.
  1. 11.   Precancer in mice: Animal models used to understand, prevent, and treat human precancers
  2. Cardiff, R. D.; Anver, M. R.; Boivin, G. P.; Bosenberg, M. W.; Maronpot, R. R.; Molinolo, A. A.; Nikitin, A. Y.; Rehg, J. E.; Thomas, G. V.; Russell, R. G.; Ward, J. M.
  3. Toxicologic Pathology. 2006 34(6): 699-707.
  1. 12.   Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Kimura, T.; Fujita, M.; Nakashima, R.; Ueda, Y.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Tanigami, A.; Yoshino, K.; Murata, Y.
  3. Cancer Research. 2005, OCT 1; 65(19): 8640-8645.
  1. 13.   Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee
  2. Shappell, S. B.; Thomas, G. V.; Roberts, R. L.; Herbert, R.; Ittmann, M. M.; Rubin, M. A.; Humphrey, P. A.; Sundberg, J. P.; Rozengurt, N.; Barrios, R.; Ward, J. M.; Cardiff, R. D.
  3. Cancer Research. 2004 64(6): 2270-2305.
  1. 14.   Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas
  2. Senchenko, V.; Liu, J.; Braga, E.; Mazurenko, N.; Loginov, W.; Seryogin, Y.; Bazov, I.; Protopopov, A.; Kisseljov, F. L.; Kashuba, V.; Lerman, M. I.; Klein, G.; Zabarovsky, E. R.
  3. Oncogene. 2003 22(19): 2984-2992.
  1. 15.   Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
  2. Hingorani, S. R.; Petricoin, E. F.; Maitra, A.; Rajapakse, V.; King, C.; Jacobetz, M. A.; Ross, S.; Conrads, T. P.; Veenstra, T. D.; Hitt, B. A.; Kawaguchi, Y.; Johann, D.; Liotta, L. A.; Crawford, H. C.; Putt, M. E.; Jacks, T.; Wright, C. V. E.; Hruban, R. H.; Lowy, A. M.; Tuveson, D. A.
  3. Cancer Cell. 2003 4(6): 437-450.
  1. 16.   Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies
  2. Wang, S. S.; Hildesheim, A.; Gao, X. J.; Schiffman, M.; Herrero, R.; Bratti, M. C.; Sherman, M. E.; Barnes, W. A.; Greenberg, M. D.; McGowan, L.; Mortel, R.; Schwartz, P. E.; Zaino, R. J.; Glass, A. G.; Burk, R. D.; Karacki, P.; Carrington, M.
  3. Journal of Infectious Diseases. 2002 186(5): 598-605.
  1. 17.   Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States)
  2. Hisada, M.; van den Berg, B. J.; Strickler, H. D.; Christianson, R. E.; Wright, W. E.; Waters, D. J.; Rabkin, C. S.
  3. Cancer Causes & Control. 2001 12(4): 335-341.
  1. 18.   Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica
  2. Wang, S. S.; Wheeler, C. M.; Hildesheim, A.; Schiffman, M.; Herrero, R.; Bratti, M. C.; Sherman, M. E.; Alfaro, M.; Hutchinson, M. L.; Morales, J.; Lorincz, A.; Burk, R. D.; Carrington, M.; Erlich, H. A.; Apple, R. J.
  3. Journal of Infectious Diseases. 2001 184(10): 1310-1314.
  1. 19.   Role of CD8 beta domains in CD8 coreceptor function: Importance for MHC I binding, signaling, and positive selection of CD8(+) T cells in the thymus
  2. Bosselut, R.; Kubo, S.; Guinter, T.; Kopacz, J. L.; Altman, J. D.; Feigenbaum, L.; Singer, A.
  3. Immunity. 2000 12(4): 409-418.
  1. 20.   Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT
  2. Wang, M.; Liu, A.; Garcia, F. U.; Rhim, J. S.; Stearns, M. E.
  3. International Journal of Oncology. 1999 14(6): 1185-1195.
  1. 21.   HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates
  2. Strickler, H. D.; Kirk, G. D.; Figueroa, J. P.; Ward, E.; Braithwaite, A. R.; Escoffery, C.; Drummond, J.; Goebel, B.; Waters, D.; McClimens, R.; Manns, A.
  3. International Journal of Cancer. 1999 80(3): 339-344.
  1. 22.   Expression of Kai1 in Paraffin-Embedded Normal, Hyperplastic and Neoplastic Prostate and Prostate Carcinoma Cell Lines
  2. Ward, J. M.; Konishi, N.; Ohshima, M.; Lamb, P. W.; Jorcyk, C. L.; Barrett, J. C.
  3. Pathology International. 1998 48(2): 87-92.
  1. 23.   Human Leukocyte Antigen Class I/Ii Alleles and Development of Human Papillomavirus-Related Cervical Neoplasia - Results From a Case-Control Study Conducted in the United States
  2. Hildesheim, A.; Schiffman, M.; Scott, D. R.; Marti, D.; Kissner, T.; Sherman, M. E.; Glass, A. G.; Manos, M. M.; Lorincz, A. T.; Kurman, R. J.; Buckl, J.; Rush, B. B.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 1998 7(11): 1035-1041.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel